Staffas, Anna
van den Brink, Marcel
Article History
First Online: 20 August 2019
Compliance with ethical standards
:
: MvdB received consulting fees from Seres Therapeutics, <i>TTT</i> Study Section, owns equity in Epiva & Evelo Theaputics, and received grant support from Seres Therapeutics, NIH, Susan and Peter Solomon Fund, and Parker Institute for Cancer Immunology. AS received grants from the Swedish research council (VR), the Swedish society for medical research (SSMF) and Assar Gabrielsson Foundation (AG Fond). There are no conflicts of interest to disclose.